Both Semaglutide and Mounjaro represent innovative strategies to managing type 2 diabetes, and increasingly, weight management. Tirzepatide is a dual molecule that targets several hormones involved in glucose regulation: this peptide and GIP. Mounjaro, often seen as a trade name for Tirzepatide,